The Local Content and Government Procurement Authority (LCGPA) recognized Sudair Pharma as a leading strategic partner in driving national healthcare localization efforts. Through an official communication published on 4 August 2024, the Authority highlighted the significant achievements resulting from the partnership between LCGPA and Sudair Pharma.
The feature emphasized Sudair Pharma’s contribution to enhancing local content in the pharmaceutical sector, supporting national economic growth, and advancing self-sufficiency in essential and specialized medicines. The recognition comes as part of an ongoing collaboration aimed at building a stronger, more sustainable pharmaceutical manufacturing ecosystem in Saudi Arabia.
Key achievements spotlighted by LCGPA include:
Accelerating localization of high-impact pharmaceutical products,
Establishing strong frameworks for measuring and improving local content,
Enhancing cooperation between national institutions and industrial partners,
Supporting Vision 2030 goals for economic diversification and health security.
Sudair Pharma expressed its appreciation for the Authority’s continued support and reaffirmed its commitment to strengthening local pharmaceutical manufacturing and expanding its national impact.
